Sana Biotechnology, Inc.
corporate_fare Company Profile
Sana Biotechnology, Inc. (NASDAQ:SANA) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 20 items for SANA at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-05, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 15 rated 8 or above. Recent SEC coverage for SANA spans 10-Q, 8-K, 424B5, S-3ASR.
Recent high-impact activity:
- Sana 10-Q: Going-Concern Warning With $121.7M Cash, Q3 Profit Is Non-Cash
- Sana Posts $20.4M Q3 Profit on Contingent Consideration Gain, Cash Down to $121.7M
- Sana's 14-Month UP421 Data Show Durable Islet Survival Without Immunosuppression
- Sana Biotechnology Warns of Going Concern as Cash Dwindles to ~$160M
- Sana Biotechnology Q2 2026: $160.5M Cash, Runway into Mid-2027, and Pipeline Momentum
Financial Snapshot
Short Interest & Short Volume
15.77 days to coverFINRA reported short interest of 40,600,271 shares in SANA as of the October 30, 2026 settlement, a 0.6% decrease from the prior period — about 15.8 days to cover at its recent average daily volume. On November 20, 2026, 60.6% of SANA volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.